Monthly Archives: October 2010

Daily Patent & CI news: 20/10/2010

Cipla launches Pirfenidone in india (BS), (Livemint) Pirfenidone is an orally active, small molecule drug, used to treat Idiopathic Pulmonary Fibrosis (IPF). InterMune licensed certain rights to pirfenidone from Marnac, Inc. and its co-licensor, KDL GmbH, in 2002. In 2007 the company purchased … Continue reading

Posted in Daily interesting IP news | Leave a comment

Daily IP News: 19/10/2010

Para IV litigation: Galderma sues Actavis for patent infringement on DIFFERIN 0.3% (Adapalene) on 15th Oct 2010 (pdf copy of complaint);  Patents in Suit US 7579377 (Exp: Feb 2025) and US 7737181 (Exp: Aug 2024) Ganzyme sues Medicis on Hyaluronic acid products … Continue reading

Posted in Daily interesting IP news | Leave a comment

Daily IP News: 18/10/2010

1) Biocon and Pfizer Enter Into Global Commercialization Agreement (Pfizer Press Release). Pfizer will have exclusive license to commercialize biocon’s biosimilar versions of Recombinant Human Insulin, Glargine , Aspart and Lispro (all are long/fast acting insulin analogs). … Under the terms of the … Continue reading

Posted in Daily interesting IP news | Leave a comment

Lupin settlement with Warner Chilcott -BS

Today BS reports, Lupins settlement with Warner Chilcott is first-of-kind, Since this settlement also helps Lupin to become authorized generic for Ascol tablets (mesalamine). Note: FamyCare (Mylan) was sued by Warner Chilcott for Femcon Fe ANDA with PIV filing (complaint) on 13th Oct … Continue reading

Posted in Patent case | Leave a comment

Drug Targets: PDE10

PDE10 is a novel CNS drug target for schizophrenia treatments. Biotie, in collaboration with Pfizer, has demonstrated that inhibitors of PDE10 are active in experimental models relevant for schizophrenia. Data from these studies were recently presented at the American Chemical … Continue reading

Posted in Drug developments & targets | Leave a comment

Daily IP news: 16/10/2010

Buisness method patenting from canada  [Patently O], [Canadaeast], [sympatico], [WSJ], [271 patent], [Federal Court of Canada] Lupin announces settlement with Warner Chilcott of Loestrin® 24 Fe and Femcon® Fe Patent Litigations [Lupin Press release], [Patent circle] P ara IV litigation on Treximate … Continue reading

Posted in Daily interesting IP news | Leave a comment

Daily IP news: 15/10/2010

Zenith Pharmaceuticals has exited its investment in Bangalore-based drug maker Strides Arcolab [ET], [BS] GSK committed to donate albendazole ; GSK will expand the production facilities by new investments in India and south africa  [GSK new release] [Rediff] [BS] Note: Novartis … Continue reading

Posted in Uncategorized | Leave a comment